MedTrace Logo

Prevalence and Impact of Diabetes Mellitus in Hospitalized COVID-19 Patients in a Tunisian Center

NCT05851820 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 866

Last updated 2023-05-10

No results posted yet for this study

Summary

Objective: The objective of this study was to evaluate the prevalence and impact of diabetes mellitus on the severity and mortality of COVID-19.

Methods: Data of laboratory-confirmed hospitalized patients at the COVID-19 unit of Ibn El Jazzar University Hospital in Kairouan between September 2020 and August 2021 were analysed, in a cross-sectional study. The population was classified into two groups (COVID-19 patients with versus without diabetes). Primary outcomes were the overall length of hospital stay, the admission to the intensive care unit (ICU), and death.

Conditions

Interventions

OTHER

comparison of outcomes/exposure

analysing if diabetes mellitus have an impact on the primary outcomes: hospital stay, admission to the ICU, death.

Sponsors & Collaborators

  • Sana Rouis

    lead OTHER

Principal Investigators

  • sana rouis, MD · Faculty of Medicine, Sousse

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-25
Primary Completion
2021-08-31
Completion
2021-08-31

Countries

  • Tunisia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05851820 on ClinicalTrials.gov